Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

38.22 -0.89 (-2.28%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

22 23 24 25 26 27 28 29 Next >

The 3 Best Biotech Stocks to Invest in for Big Gains in 2024 ↗

February 02, 2024

These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns

Via InvestorPlace

2 Rising Biotechs That Could Become the Next Novo Nordisk ↗

January 29, 2024

Each of these companies has a big market in its sights.

Via The Motley Fool

3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024 ↗

January 22, 2024

Biotech stocks are some of the most exciting opportunities on the market. Find the right ones with catalysts, and you could make a fortune.

Via InvestorPlace

2 Stocks That Could Soar This Year: Are They Buys? ↗

January 22, 2024

They might perform well in 2024, but how will they do beyond that?

Via The Motley Fool

2 biotechs with promising weight-loss drugs coming

January 16, 2024

Clinical weight-loss medications have been making headlines as GLP-1 drugs like Novo Nordisk A/S (NYSE: NVO) owned Ozempic and Wegovy and Eli Lilly and Co.

Via MarketBeat

1 Under-the-Radar Stock That Could Triple By 2030 ↗

November 04, 2023

This small-cap biotech stock is going to compete against some giants.

Via The Motley Fool

Earnings Scheduled For October 25, 2023 ↗

October 25, 2023

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.

Via Benzinga

2 Magnificient Growth Stocks I'm Buying in August ↗

August 02, 2023

These biotech stocks could markedly outperform the broader market.

Via The Motley Fool

9 Analysts Have This to Say About Viking Therapeutics ↗

July 27, 2023

Via Benzinga

The 3 Best Biotech Stocks to Buy in January 2024 ↗

January 09, 2024

Biotech is still one of the most exciting investments on the market, creating substantial opportunities for some of the best biotech stocks.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

January 09, 2024

Via Benzinga

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024 ↗

January 02, 2024

Lower interest rates and the low valuation of many biotech stocks are likely to result in many drug maker stocks being acquired in 2024.

Via InvestorPlace

Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics? ↗

December 12, 2023

Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.

Via The Motley Fool

Why Viking Therapeutics Was Crushing It This Week ↗

December 08, 2023

Nowadays, it's good to be a developer of next-generation weight loss drugs.

Via The Motley Fool

Earnings Preview: Viking Therapeutics ↗

July 25, 2023

Via Benzinga

What's Going On With Viking Therapeutics Shares Tuesday? ↗

November 14, 2023

Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company presented new data from its Phase 2b study

Via Benzinga

Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders

October 19, 2023

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END

Via FinancialNewsMedia

Why Are Stocks Down Today? ↗

October 18, 2023

Stocks are down again on Wednesday as investors continue to feel the effects of several major catalysts hitting the market.

Via InvestorPlace

Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts ↗

October 18, 2023

Pfizer layoffs are a hot topic among PFE stock traders on Wednesday as they pour over the details of the job cuts amid a Covid slump.

Via InvestorPlace

Topics Workforce

Why Is Viking Therapeutics (VKTX) Stock Moving Today? ↗

October 18, 2023

Viking Therapeutics stock is on the move Wednesday as investors react to results from the company's latest clinical trial!

Via InvestorPlace

Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 18, 2023

Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court...

Via Benzinga

Topics Bankruptcy

Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business' ↗

October 11, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair.

Via Benzinga

Consolidation In Viking Therapeutics Provides An Opportunity ↗

October 01, 2023

Viking Therapeutics Inc. (VKTX) is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases.

Via Talk Markets

Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday ↗

September 18, 2023

U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy? ↗

August 23, 2023

NASH treatments are projected to be one of the most sought-after indications in the coming years.

Via The Motley Fool

Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It ↗

August 23, 2023

NASH is a surprisingly common ailment, and the first treatments are on the way.

Via The Motley Fool

The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023 ↗

August 16, 2023

All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 08, 2023

Via Benzinga

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today ↗

August 08, 2023

Novo Nordisk's popular weight loss drug also confers a significant cardioprotective effect, according to a new study.

Via The Motley Fool

Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush

July 24, 2023

A bid to acquire Versanis boosts Eli Lilly & Co. by 2.80% in the past week, as the competition to develop the most effective weight-loss drug intensifies.

Via MarketBeat

< Previous 1 2

...

22 23 24 25 26 27 28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

All News about Viking Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today